| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 487.543 | 1.095.756 | 1.060.914 | 523.017 | 975 | 1.620 | 0 | 0 | 0 |
| Total Income - EUR | 18 | 491.861 | 1.121.173 | 1.070.494 | 560.928 | 15.486 | 1.787 | 7 | 8 | 4.035 |
| Total Expenses - EUR | 628 | 407.763 | 831.416 | 764.372 | 333.897 | 21.866 | 12.289 | 5.045 | 566 | 489 |
| Gross Profit/Loss - EUR | -609 | 84.097 | 289.756 | 306.122 | 227.032 | -6.381 | -10.502 | -5.038 | -559 | 3.546 |
| Net Profit/Loss - EUR | -609 | 70.771 | 252.908 | 261.551 | 189.399 | -6.818 | -10.554 | -5.038 | -559 | 3.068 |
| Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Ubm Protein S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.379 | 22.641 | 10.661 | 41.150 | 47.069 | 471 | 248 | 36 | 0 | 0 |
| Current Assets | 10.537 | 368.304 | 389.604 | 384.891 | 301.536 | 31.412 | 5.131 | 1.419 | 1.545 | 228 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 281.989 | 226.195 | 359.409 | 279.106 | 16.889 | 3.471 | 1.301 | 1.369 | 175 |
| Cash | 10.537 | 86.316 | 163.408 | 25.482 | 22.430 | 14.523 | 1.660 | 118 | 175 | 53 |
| Shareholders Funds | -384 | 70.391 | 253.171 | 261.809 | 189.679 | 2.760 | 2.725 | -2.304 | -2.856 | 228 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 19.300 | 320.554 | 147.094 | 164.233 | 158.926 | 29.122 | 2.654 | 3.759 | 4.400 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4611 - 4611" | |||||||||
| CAEN Financial Year |
4611
|
|||||||||
Comments - Ubm Protein S.r.l.